Can an immune-targeting antibody reverse sudden losses in down syndrome?
Disease control
Not yet recruiting
Down syndrome regression disorder (DSRD) causes a sudden loss of thinking, language, or daily skills in some people with Down syndrome. Researchers are testing ublituximab, an antibody that targets immune cells, in 20 adults aged 18 to 40 who have DSRD and did not respond well en…
Phase 2 • Sponsor: Jonathan Santoro • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC